CureDuchenne and NS Pharma: VILTEPSO

This is a pre-recorded webinar with CureDuchenne, NS Pharma and guest speaker Dr. Mathula Thangarajh.

Topics include:

• Clinical evidence to support early initiation of DMD treatment

• The role of exon skipping in the treatment of DMD

• The efficacy of VILTEPSO for the treatment of DMD

• The safety and tolerability profile of VILTEPSO

Mathula Thangarajh, MD, PhD, FAAN

Related Resources

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.